美国 · SEC FORM 4
ABEONA THERAPEUTICS INC.
ABEO · Nasdaq · CIK 0000318306 · Healthcare · Biotechnology
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
26 同一窗口内观察到的 Form 4 交易行
24 sales · 2 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
Showing the six most active owners; 2 additional owner(s) remain in Form 4 申报证据.
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2024-05-16 · Alland Leila.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息，不影响内部人信号。
价格表现
- 1M
- -12.5%
- 3M
- -16.2%
- 6M
- +22.5%
- 12M
- —
波动率与流动性
- 波动率
- 53.0%
- Beta
- 1.32
- 平均每日成交额
- USD 7.6M
估值
- 市值
- USD 296.2M
- P/E
- —
基本面
- 利润率
- -246.4%
- ROE
- -44.7%
- 细分行业
- Biotechnology
市场数据
价格数据截至：2026-09-29 · 价格来源：OpenBB/yfinance · 来自 SEC 申报文件：ROE · 财年截止日：2025-12-31 · 来自 Yahoo Finance：市值, 利润率 · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 16,882,889
- 上期报告
- 15,745,098
- 日均成交量
- 1,459,538
- 回补天数
- 11.6
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2024-05-16 | Alland Leila | 买入 (P) | Common Stock | 11,000 | USD 4.71 | USD 51,810 | SEC 申报 ↗ |
| 2024-04-26 | Charles Faith L. | 买入 (P) | Common Stock | 7,550 | USD 3.28 | USD 24,764 | SEC 申报 ↗ |
| 2024-04-25 | Seshadri Vishwas | 买入 (P) | Common Stock | 10,000 | USD 3.20 | USD 32,000 | SEC 申报 ↗ |
| 2024-04-25 | Vazzano Joseph Walter | 买入 (P) | Common stock | 5,608 | USD 3.14 | USD 17,609 | SEC 申报 ↗ |
| 2024-04-25 | O'Malley Brendan M. | 买入 (P) | Common stock | 8,600 | USD 3.24 | USD 27,864 | SEC 申报 ↗ |
| 2024-02-06 | Seshadri Vishwas | 买入 (P) | Common Stock | 20,000 | USD 4.39 | USD 87,800 | SEC 申报 ↗ |
| 2023-09-27 | Seshadri Vishwas | 买入 (P) | Common Stock | 20,000 | USD 4.07 | USD 81,400 | SEC 申报 ↗ |
| 2023-09-19 | Vazzano Joseph Walter | 买入 (P) | Common stock | 3,000 | USD 3.82 | USD 11,458 | SEC 申报 ↗ |
| 2023-09-18 | O'Malley Brendan M. | 买入 (P) | Common stock | 3,000 | USD 3.80 | USD 11,400 | SEC 申报 ↗ |
| 2022-12-09 | O'Malley Brendan M. | 买入 (P) | Common stock | 5,869 | USD 3.13 | USD 18,370 | SEC 申报 ↗ |
| 2022-11-18 | Vazzano Joseph Walter | 买入 (P) | Common stock | 2,500 | USD 4.00 | USD 10,000 | SEC 申报 ↗ |
| 2022-11-18 | O'Malley Brendan M. | 买入 (P) | Common stock | 7,500 | USD 3.99 | USD 29,925 | SEC 申报 ↗ |
Form 4 申报证据
53 transaction lines in the latest 365-day window; 259 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-29 | Vazzano Joseph Walter | 卖出 (S) | Common Stock | 9,191 | USD 5.16 | USD 47,426 | SEC 申报 ↗ |
| 2026-09-29 | Vasanthavada Madhav | 卖出 (S) | Common Stock | 4,902 | USD 5.16 | USD 25,294 | SEC 申报 ↗ |
| 2026-09-29 | Seshadri Vishwas | 卖出 (S) | Common Stock | 19,608 | USD 5.16 | USD 101,177 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-29 | Vazzano Joseph Walter | 卖出 (S) | Common Stock | 9,191 | USD 5.16 | USD 47,426 | SEC 申报 ↗ |
| 2026-09-29 | Vasanthavada Madhav | 卖出 (S) | Common Stock | 4,902 | USD 5.16 | USD 25,294 | SEC 申报 ↗ |
| 2026-09-29 | Seshadri Vishwas | 卖出 (S) | Common Stock | 19,608 | USD 5.16 | USD 101,177 | SEC 申报 ↗ |
| 2026-09-29 | O'Malley Brendan M. | 卖出 (S) | Common Stock | 6,727 | USD 5.16 | USD 34,711 | SEC 申报 ↗ |
| 2026-09-01 | Alvino Mark | 卖出 (S) | Common Stock | 15,000 | USD 5.86 | USD 87,900 | SEC 申报 ↗ |
| 2026-07-21 | Vazzano Joseph Walter | 卖出 (S) | Common Stock | 1,478 | USD 6.53 | USD 9,651 | SEC 申报 ↗ |
| 2026-07-09 | Vazzano Joseph Walter | 卖出 (S) | Common Stock | 24,880 | USD 6.96 | USD 173,165 | SEC 申报 ↗ |
| 2026-07-09 | Vasanthavada Madhav | 卖出 (S) | Common Stock | 12,606 | USD 6.96 | USD 87,738 | SEC 申报 ↗ |
| 2026-07-09 | Seshadri Vishwas | 卖出 (S) | Common Stock | 67,971 | USD 6.96 | USD 473,078 | SEC 申报 ↗ |
| 2026-07-09 | O'Malley Brendan M. | 卖出 (S) | Common Stock | 12,050 | USD 6.96 | USD 83,868 | SEC 申报 ↗ |
| 2026-06-30 | Alland Leila | 卖出 (S) | Common Stock | 11,000 | USD 5.92 | USD 65,120 | SEC 申报 ↗ |
| 2026-06-16 | Vasanthavada Madhav | J (J) | Common Stock | 222 | USD 5.67 | USD 1,259 | SEC 申报 ↗ |
| 2026-06-15 | Silverstein Christine Berni | 卖出 (S) | Common Stock | 18,160 | USD 5.71 | USD 103,694 | SEC 申报 ↗ |
| 2026-06-09 | Vazzano Joseph Walter | 卖出 (S) | Common Stock | 39,067 | USD 5.36 | USD 209,363 | SEC 申报 ↗ |
| 2026-06-09 | Vasanthavada Madhav | 卖出 (S) | Common Stock | 5,450 | USD 5.30 | USD 28,885 | SEC 申报 ↗ |
| 2026-06-09 | Seshadri Vishwas | 卖出 (S) | Common Stock | 31,916 | USD 5.30 | USD 169,155 | SEC 申报 ↗ |
| 2026-06-09 | O'Malley Brendan M. | 卖出 (S) | Common Stock | 6,305 | USD 5.30 | USD 33,416 | SEC 申报 ↗ |
| 2026-06-08 | Vazzano Joseph Walter | 卖出 (S) | Common Stock | 10,271 | USD 5.43 | USD 55,772 | SEC 申报 ↗ |
| 2026-06-08 | Vasanthavada Madhav | 卖出 (S) | Common Stock | 4,170 | USD 5.43 | USD 22,643 | SEC 申报 ↗ |
| 2026-06-08 | Seshadri Vishwas | 卖出 (S) | Common Stock | 24,428 | USD 5.43 | USD 132,644 | SEC 申报 ↗ |
| 2026-06-08 | O'Malley Brendan M. | 卖出 (S) | Common Stock | 4,826 | USD 5.43 | USD 26,205 | SEC 申报 ↗ |
| 2026-05-26 | Alvino Mark | 赠与 (G) | Common Stock | 500 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-22 | Alvino Mark | 卖出 (S) | Common Stock | 6,500 | USD 5.46 | USD 35,490 | SEC 申报 ↗ |
| 2026-05-15 | Crombez Eric | 卖出 (S) | Common Stock | 26,143 | USD 5.53 | USD 144,571 | SEC 申报 ↗ |
| 2026-05-11 | Vasanthavada Madhav | 卖出 (S) | Common Stock | 5,548 | USD 5.96 | USD 33,066 | SEC 申报 ↗ |
| 2026-04-01 | Goldan Keith A. | 奖励／授予 (A) | Common Stock | 32,751 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-31 | Seshadri Vishwas | 卖出 (S) | Common Stock | 29,985 | USD 4.38 | USD 131,334 | SEC 申报 ↗ |
| 2026-03-16 | Vazzano Joseph Walter | 卖出 (S) | Common Stock | 785 | USD 4.76 | USD 3,737 | SEC 申报 ↗ |
| 2026-02-02 | Silverstein Christine Berni | 卖出 (S) | Common Stock | 20,070 | USD 5.09 | USD 102,156 | SEC 申报 ↗ |
| 2026-02-02 | Wuchterl Donald A. | 卖出 (S) | Common Stock | 14,814 | USD 5.09 | USD 75,403 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-19 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | ABEO |
| CIK | 0000318306 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 259 transaction lines from 2020-03-19 to 2026-09-29 13 P purchase lines · 113 S sale lines · 133 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.